Routine Prophylaxis of Pneumocystis Jirovecii Pneumonia in Recipients of Autologous Hematopoietic Stem Cell Transplantation

被引：2
|
作者：
Raser, Kadee [1 ]
McNulty, Mary Lea [1 ]
Yanik, Gregory [2 ]
Goldstein, Steven C. [3 ]
Magenau, John [3 ]
Pawarode, Attaphol [3 ]
Kitko, Carrie L. [1 ]
Hanauer, David [1 ]
Levine, John [4 ]
Couriel, Daniel R. [3 ]
机构：
[1] Univ Michigan, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Blood & Marrow Transplant Program, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Adult Blood & Marrow Transplant Program, Ann Arbor, MI 48109 USA
[4] Univ Michigan, Pediat Blood & Marrow Transplant Program, Ann Arbor, MI 48109 USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2014年 / 20卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2013.12.170
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
150
引用
收藏
页码：S116 / S117
页数：2
相关论文
共 50 条
  • [31] Risk factors for Pneumocystis jirovecii pneumonia (PJP) in kidney transplantation recipients
    Su Hwan Lee
    Kyu Ha Huh
    Dong Jin Joo
    Myoung Soo Kim
    Soon Il Kim
    Juhan Lee
    Moo Suk Park
    Young Sam Kim
    Se Kyu Kim
    Joon Chang
    Yu Seun Kim
    Song Yee Kim
    Scientific Reports, 7
  • [32] Contemporary US Prevalence and Outcomes of Pneumocystis jirovecii Pneumonia and Toxoplasmosis in Pediatric Solid Organ and Hematopoietic Cell Transplantation Recipients.
    Ardura, M. I.
    Stanek, J.
    Hanisch, B.
    Hanisch, B.
    Sprott, K.
    Rangarajan, H.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 416 - 417
  • [33] IMPROVING ADHERENCE TO PNEUMOCYSTIS JIROVECII PNEUMONIA (PJP) PROPHYLAXIS IN LUNG TRANSPLANT RECIPIENTS
    Djavadkhani, Y.
    Harkess, M.
    Carlos, L.
    Glanville, A. R.
    IMMUNOLOGY AND CELL BIOLOGY, 2013, 91 (08): : A26 - A26
  • [34] Risk factors for Pneumocystis jirovecii pneumonia (PJP) in kidney transplantation recipients
    Lee, Su Hwan
    Huh, Kyu Ha
    Joo, Dong Jin
    Kim, Myoung Soo
    Kim, Soon Il
    Lee, Juhan
    Park, Moo Suk
    Kim, Young Sam
    Kim, Se Kyu
    Chang, Joon
    Kim, Yu Seun
    Kim, Song Yee
    SCIENTIFIC REPORTS, 2017, 7
  • [35] Incidence of Pneumocystis Jirovecii Infection and Duration of Prophylaxis After Allogeneic Stem Cell Transplantation
    Mishra, Asmita
    Chavez, Julio C.
    Tomblyn, Marcie
    Anasetti, Claudio
    Ayala, Ernesto
    Field, Teresa
    Kharfan-Dabaja, Mohamed
    Perez, Lia Elena
    Fernandez, Hugo
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (02) : S267 - S268
  • [36] Atovaquone for Pneumocystis carinii-pneumonia prophylaxis in allogeneic stem transplantation recipients.
    Ippoliti, C
    Bethancourt, D
    Donato, ML
    BLOOD, 2002, 100 (11) : 626A - 626A
  • [37] Prophylaxis Against Pneumocystis jirovecii Pneumonia in Adults
    Zhou, Shiwei
    Aitken, Samuel L.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 330 (02): : 182 - 183
  • [38] Pneumocystis jirovecii pneumonia: still a concern in patients with haematological malignancies and stem cell transplant recipients
    Cordonnier, Catherine
    Cesaro, Simone
    Maschmeyer, Georg
    Einsele, Hermann
    Donnelly, J. Peter
    Alanio, Alexandre
    Hauser, Philippe M.
    Lagrou, Katrien
    Melchers, Willem J. G.
    Helweg-Larsen, Jannik
    Matos, Olga
    Bretagne, Stephane
    Maertens, Johan
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2016, 71 (09) : 2379 - 2385
  • [39] Pneumocystis jirovecii pneumonia in kidney transplantation
    Goto, N.
    Oka, S.
    TRANSPLANT INFECTIOUS DISEASE, 2011, 13 (06) : 551 - 558
  • [40] Prescribing rates of pneumocystis jirovecii pneumonia prophylaxis
    Foo, Yun Megan
    Lennon, Tamara
    Chin, Melvin
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022, 18 : 180 - 180
12345